Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Sep, 2018 | Pages:
155 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)
The global metagenomics market size is expected to reach USD 1.40 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 16.6% during the forecast period. Rise in demand for microbial screening in food and chemical industries for commercial applications, coupled with rapid developments in bioinformatics and biotechnology tools, is anticipated to accelerate market growth in the coming years. Key market participants are striving to capitalize potential avenues in the market by addressing challenges faced by research entities pertaining to data assembly, identification, and verification of rare metagenomes. Furthermore, companies operating in the molecular diagnostics and genomics arena are a playing crucial role in this market by partnering with metagenomics companies for development of novel tests for disease diagnosis. For instance, in September 2017, IDbyDNA, Inc. and ARUP Laboratories co-developed Explify Respiratory-a metagenomic NGS test for screening of respiratory infections. The anticipated launch of many such novel tests is projected to boost the market during the forecast period. Further key findings from the report suggest: • Kits and reagents formed the largest segment by product in 2017 owing to frequent usage at various steps in microbial genomic studies • Surplus growth in genomics database with respect to types and numbers has led to rising demand for better data analysis solutions. As a result, the sequencing and data analytics services segment is expected to emerge as a lucrative source of revenue generation during the forecast period • Function driven technology held the major revenue share in 2017. Development of new screening procedures that facilitate rapid screening of large clone libraries has enabledfunctional detection of novel enzymes from metagenomes • Advancements in genetic tools have broadened the application scope of metagenomics to include targeting microbes responsible for inducing various cancer forms. This, in turn, is driving the application of metagenomic analysis in human health • North America dominated the market in 2017. Strong presence of key NGS leaders like Illumina and a substantial number of ongoing genomics-related studies in U.S. are major factors contributing to its large share • Some of the key competitors in the market are Illumina, Inc.; Promega Corporation; Novogene Corporation; Oxford Gene Technology, Inc.; Thermo Fisher Scientific, Inc.; TAKARA BIO INC.; Danaher; QIAGEN; and ELITechGroup • Acquisition of small players with a strong product portfolio is a prominently adopted strategy by dominant players. For instance, in August 2016, PerkinElmer acquired Bioo Scientific Corporation-provider of 16S & 18S library preparation kits for metagenome studies • Competitors are also involved in collaborations with bioinformatics companies for co-development of novel platforms for metagenomics analysis.
Table of Contents
Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 GVR's internal database
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Approaches for Market Estimation
2.4.1 Approach 1: Commodity flow & bottom up approach
2.4.2 Approach 2: Top down and parent market analysis
Chapter 3 Metagenomics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Declining expenses of sequencing
3.1.1.1.1 Decline in cost of per genome sequencing 2010 to 2016
3.1.1.1.2 Decline in cost of per Megabase DNA sequencing 2010 to 2016
3.1.1.2 Developments in biotechnology & bioinformatics techniques
3.1.1.3 Interest in microbial screening for different investigations
3.1.1.3.1 Number of metagenomics studies registered in Integrated Microbial Genomes & Microbiomes (IMG/M) web server 2017
3.1.1.4 Emergence of new fields in genomics that complement metagenomics
3.1.2 Market restraint analysis
3.1.2.1 Limited accessibility to computation and different analytic tools
3.1.2.2 High overall cost of metagenomics
3.2 Penetration & Growth Prospect Mapping for Application, 2017
3.3 Metagenomics - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter's
Chapter 4 Metagenomics Market Categorization: Product Estimates & Trend Analysis
4.1 Global Metagenomics Market: Product Movement Analysis, 2017 & 2025
4.2 Kits & Reagents
4.2.1 Global metagenomics kits & reagent market, 2014 - 2025 (USD Million)
4.3 Sequencing & Data Analytics Services
4.3.1 Global sequencing & data analytics services market, 2014 - 2025 (USD Million)
4.4 Others
4.4.1 Global other products market, 2014 - 2025 (USD Million)
Chapter 5 Metagenomics Market Categorization: Technology Estimates & Trend Analysis
5.1 Global Metagenomics Market: Technology Movement Analysis, 2017 & 2025
5.2 Sequencing Driven Metagenomics
5.2.1 Global sequencing driven metagenomics market, 2014 - 2025 (USD Million)
5.3 Function Driven Metagenomics
5.3.1 Global function driven metagenomics market, 2014 - 2025 (USD Million)
Chapter 6 Metagenomics Market Categorization: Application Estimates & Trend Analysis
6.1 Global Metagenomics Market: Application Movement Analysis, 2017 & 2025
6.2 Environmental
6.2.1 Global environmental metagenomics market, 2014 - 2025 (USD Million)
6.3 Human Health
6.3.1 Global human health metagenomics market, 2014 - 2025 (USD Million)
6.4 Others
6.4.1 Global other metagenomics applications market, 2014 - 2025 (USD Million)
Chapter 7 Metagenomics Market Categorization: Regional Estimates & Trend Analysis, by Product, Technology & Applications
7.1 Metagenomics Market Share By Region, 2017 & 2025
7.2 North America
7.2.1 North America metagenomics market, by product, 2014 - 2025 (USD Million)
7.2.2 North America metagenomics market, by technology, 2014 - 2025 (USD Million)
7.2.3 North America metagenomics market, by application, 2014 - 2025 (USD Million)
7.2.4 U.S.
7.2.4.1 U.S. metagenomics market, by product 2014 - 2025 (USD Million)
7.2.4.2 U.S. metagenomics market, by technology 2014 - 2025 (USD Million)
7.2.4.3 U.S. metagenomics market, by application 2014 - 2025 (USD Million)
7.2.5 Canada
7.2.5.1 Canada metagenomics market, by product 2014 - 2025 (USD Million)
7.2.5.2 Canada metagenomics market, by technology 2014 - 2025 (USD Million)
7.2.5.3 Canada metagenomics market, by application 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe metagenomics market, by product, 2014 - 2025 (USD Million)
7.3.2 Europe metagenomics market, by technology, 2014 - 2025 (USD Million)
7.3.3 Europe metagenomics market, by application, 2014 - 2025 (USD Million)
7.3.4 Germany
7.3.4.1 Germany metagenomics market, by product 2014 - 2025 (USD Million)
7.3.4.2 Germany metagenomics market, by technology 2014 - 2025 (USD Million)
7.3.4.3 Germany metagenomics market, by application 2014 - 2025 (USD Million)
7.3.5 U.K.
7.3.5.1 U.K. metagenomics market, by product 2014 - 2025 (USD Million)
7.3.5.2 U.K. metagenomics market, by technology 2014 - 2025 (USD Million)
7.3.5.3 U.K. metagenomics market, by application 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific metagenomics market, by product, 2014 - 2025 (USD Million)
7.4.2 Asia Pacific metagenomics market, by technology, 2014 - 2025 (USD Million)
7.4.3 Asia Pacific metagenomics market, by application, 2014 - 2025 (USD Million)
7.4.4 Japan
7.4.4.1 Japan metagenomics market, by product 2014 - 2025 (USD Million)
7.4.4.2 Japan metagenomics market, by technology 2014 - 2025 (USD Million)
7.4.4.3 Japan metagenomics market, by application 2014 - 2025 (USD Million)
7.4.5 China
7.4.5.1 China metagenomics market, by product 2014 - 2025 (USD Million)
7.4.5.2 China metagenomics market, by technology 2014 - 2025 (USD Million)
7.4.5.3 China metagenomics market, by application 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America metagenomics market, by product, 2014 - 2025 (USD Million)
7.5.2 Latin America metagenomics market, by technology, 2014 - 2025 (USD Million)
7.5.3 Latin America metagenomics market, by application, 2014 - 2025 (USD Million)
7.5.4 Brazil
7.5.4.1 Brazil metagenomics market, by product 2014 - 2025 (USD Million)
7.5.4.2 Brazil metagenomics market, by technology 2014 - 2025 (USD Million)
7.5.4.3 Brazil metagenomics market, by application 2014 - 2025 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 Middle East & Africa metagenomics market, by product, 2014 - 2025 (USD Million)
7.6.2 Middle East & Africa metagenomics market, by technology, 2014 - 2025 (USD Million)
7.6.3 Middle East & Africa metagenomics market, by application, 2014 - 2025 (USD Million)
7.6.4 South Africa
7.6.4.1 South Africa metagenomics market, by product 2014 - 2025 (USD Million)
7.6.4.2 South Africa metagenomics market, by technology 2014 - 2025 (USD Million)
7.6.4.3 South Africa metagenomics market, by application 2014 - 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 List of Companies
8.4 Company Profiles
8.4.1 QIAGEN
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 F. Hoffmann-La Roche Ltd
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 Illumina, Inc.
8.4.3.1 Company Overview
8.4.3.2 Financial Performance
8.4.3.3 Product Benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 Novogene Corporation
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 PerkinElmer Inc.
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 Bio-Rad Laboratories
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 Thermo Fisher Scientific, Inc.
8.4.7.1 Company overview
8.4.7.1.1 Life Technologies Corporation
8.4.7.1.2 Affymetrix, Inc.
8.4.7.2 Financial performance
8.4.7.2.1 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 Merck KGaA
8.4.8.1 Company overview
8.4.8.1.1 Sigma-Aldrich Co. LLC.
8.4.8.2 Financial performance
8.4.8.2.1 Financial performance (2014)
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 Agilent Technologies
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 Promega Corporation
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
8.4.11 Luminex Corporation
8.4.11.1 Company overview
8.4.11.2 Financial performance
8.4.11.3 Product benchmarking
8.4.12 Oxford Gene Technology, Inc.
8.4.12.1 Company overview
8.4.12.2 Financial performance
8.4.12.3 Product benchmarking
8.4.12.4 Strategic initiatives
8.4.13 TAKARA BIO INC.
8.4.13.1 Company overview
8.4.13.1.1 WaferGen Bio-systems, Inc.
8.4.13.2 Financial performance
8.4.13.2.1 Financial performance
8.4.13.3 Product benchmarking
8.4.13.4 Strategic initiatives
8.4.14 Danaher
8.4.14.1 Company overview
8.4.14.1.1 Cepheid
8.4.14.2 Financial performance
8.4.14.2.1 Financial performance
8.4.14.3 Product benchmarking
8.4.14.4 Strategic initiatives
8.4.15 ELITechGroup
8.4.15.1 Company overview
8.4.15.2 Financial performance
8.4.15.3 Product benchmarking
8.4.15.4 Strategic initiatives
8.4.16 AutoGenomics
8.4.16.1 Company overview
8.4.16.2 Financial Performance
8.4.16.3 Product benchmarking
8.4.16.4 Strategic initiatives
8.4.17 Biocartis Group NV
8.4.17.1 Company overview
8.4.17.2 Financial performance
8.4.17.3 Product benchmarking
8.4.17.4 Strategic initiatives
8.4.18 IntegraGen.
8.4.18.1 Company overview
8.4.18.2 Financial performance
8.4.18.3 Product benchmarking
8.4.18.4 Strategic initiatives
8.4.19 ChunLab, Inc.
8.4.19.1 Company overview
8.4.19.2 Financial performance
8.4.19.3 Product benchmarking
8.4.19.4 Strategic initiatives
8.4.20 uBiome, Inc.
8.4.20.1 Company overview
8.4.20.2 Financial performance
8.4.20.3 Product benchmarking
8.4.20.4 Strategic initiatives
List of Tables TABLE 1 Nucleic acid sequence and omics data repositories TABLE 2 Recent patents in metagenomics TABLE 3 Features offered by current bioinformatics platforms for metagenomics pipeline analysis TABLE 4 Some novel enzymes discovered through metagenomics in recent years TABLE 5 Various NGS platforms widely used in metagenomics TABLE 6 Use of metagenomics in diagnostics TABLE 7 Comparison among different diagnostic techniques TABLE 8 North America metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 9 North America metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 10 North America metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 11 U.S. metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 12 U.S. metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 13 U.S. metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 14 Canada metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 15 Canada metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 16 Canada metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 17 Europe metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 18 Europe metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 19 Europe metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 20 Germany metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 21 Germany metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 22 Germany metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 23 U.K. metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 24 U.K. metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 25 U.K. metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 26 Asia Pacific metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 27 Asia Pacific metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 28 Asia Pacific metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 29 Japan metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 30 Japan metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 31 Japan metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 32 China metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 33 China metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 34 China metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 35 Latin America metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 36 Latin America metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 37 Latin America metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 38 Brazil metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 39 Brazil metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 40 Brazil metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 41 MEA metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 42 MEA metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 43 MEA metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million) TABLE 44 South Africa metagenomics market estimates &forecasts, by product, 2014 - 2025 (USD Million) TABLE 45 South Africa metagenomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million) TABLE 46 South Africa metagenomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
List of Figures FIG. 1 Market research process FIG. 2 Information Procurement FIG. 3 Primary research pattern FIG. 4 Market research approaches FIG. 5 Value chain based sizing & forecasting FIG. 6 QFD modelling for market share assessment FIG. 7 Market summary FIG. 8 Market trends & outlook FIG. 9 Market segmentation & scope FIG. 10 Market driver relevance analysis (Current & future impact) FIG. 11 Decline in cost of per genome sequencing 2010 to 2016 FIG. 12 Decline in cost of per Megabase DNA sequencing 2010 to 2016 FIG. 13 Number of metagenomics studies registered in Integrated Microbial Genomes & Microbiomes (IMG/M) web server 2017 FIG. 14 Market restraint relevance analysis (Current & future impact) FIG. 15 Penetration & growth prospect mapping for application, 2017 FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological) FIG. 17 Porter's Five Forces Analysis FIG. 18 Metagenomics market: Product outlook key takeaways FIG. 19 Metagenomics market: Product movement analysis FIG. 20 Global metagenomics kits & reagent market, 2014 - 2025 (USD Million) FIG. 21 Global sequencing & data analytics services market, 2014 - 2025 (USD Million) FIG. 22 Global other products market, 2014 - 2025 (USD Million) FIG. 23 Global metagenomics market: Technology outlook key takeaways FIG. 24 Metagenomics market: Technology movement analysis FIG. 25 Global sequencing driven metagenomics market, 2014 - 2025 (USD Million) FIG. 26 Global function driven metagenomics market, 2014 - 2025 (USD Million) FIG. 27 Global metagenomics market: Application outlook key takeaways FIG. 28 Metagenomics market: Application movement analysis FIG. 29 Global environmental metagenomics market, 2014 - 2025 (USD Million) FIG. 30 Global human health metagenomics market, 2014 - 2025 (USD Million) FIG. 31 Global other metagenomics applications market, 2014 - 2025 (USD Million) FIG. 32 Regional market place: Key takeaway FIG. 33 Metagenomics regional outlook, 2017 & 2025 FIG. 34 North America metagenomics market, 2014 - 2025 (USD Million) FIG. 35 U.S metagenomics market, 2014 - 2025 (USD Million) FIG. 36 Canada metagenomics market, 2014 - 2025 (USD Million) FIG. 37 Europe metagenomics market, 2014 - 2025 (USD Million) FIG. 38 Germany metagenomics market, 2014 - 2025 (USD Million) FIG. 39 U.K. metagenomics market, 2014 - 2025 (USD Million) FIG. 40 Asia Pacific metagenomics market, 2014 - 2025 (USD Million) FIG. 41 Japan metagenomics market, 2014 - 2025 (USD Million) FIG. 42 China metagenomics market, 2014 - 2025 (USD Million) FIG. 43 Latin America metagenomics market, 2014 - 2025 (USD Million) FIG. 44 Brazil metagenomics market, 2014 - 2025 (USD Million) FIG. 45 Middle East & Africa metagenomics market, 2014 - 2025 (USD Million) FIG. 46 South Africa metagenomics market, 2014 - 2025 (USD Million) FIG. 47 Strategy framework FIG. 48 Participant categorization FIG. 49 List of companies
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
